Reza Rahmanzadeh


Senior Researcher, Quantitative Magnetic Resonance Imaging in Multiple Sclerosis



• 2003-2011 Secondary school at The National Organization for Development of Exceptional Talents, Iran.

• 2011-2018 Medical student at Iran University of Medical Sciences (IUMS), Tehran, Iran.

• 2016 Research Fellow, University Medical Center Göttingen, Göttingen, Germany.

• 2019-2022 PhD candidate, Department of Biomedical Engineering, University of Basel, Switzerland.

• 2022-Now Senior researcher/Neuroradiology resident, Neuroradiology Department, Inselspital, Bern, Switzerland.



• 2022 Peter-Huber prize, Swiss Society for Neuroradiology.

• 2022 Summa Cum Laude, PhD dissertation, University of Basel.

• 2021 Best Oral Presentation, Quantitative MRI Research Group, International Society for Magnetic Resonance in Medicine (ISMRM).

• 2021/2020 Magna Caum Laude, International Society for Magnetic Resonance in Medicine (ISMRM) Merit Award.

• 2022/2021/2020 Young Investigator Grant, Joint American & European Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS & ECTRIMS).

• 2021/2020 Swiss Government Excellence Scholarships, Extended.

• 2021/2020 Educational Scholarship, International Society for Magnetic Resonance in Medicine


• 2019 McDonald Fellowship, Multiple Sclerosis International Federation (MSIF).

• 2019 Swiss Government Excellence Scholarships.

• 2016 Du Pre Grant, Multiple Sclerosis International Federation (MSIF).

• 2016 Best Young Investigator Reward, Basic & Clinical Neuroscience Congress, Iran.

• 2015 Bronze medal, National Medicine Olympiad, Iran.

• 2009 Silver medal, National Astronomy Olympiad, Iran.

• 2008 Gold medal, National Computer Science Olympiad, Iran.


Research interests

• Quantitative magnetic resonance imaging

• Demyelinating disorders


Selected publications

Rahmanzadeh et al., A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis, Annals of Neurology, 2022;92:486-502.

Rahmanzadeh et al., Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging, Brain, 2021 Jul 28;144(6):1684-1696.

Rahmanzadeh et al. "Multiple sclerosis pathogenesis: missing pieces of an old puzzle." Reviews in the Neurosciences 30.1 (2019): 67-83.

Rahmanzadeh et al. "B cells in multiple sclerosis therapy—A comprehensive review." Acta Neurologica Scandinavica 137.6 (2018): 544-556.

Rahmanzadeh et al. "Demyelination with preferential MAG loss: a complex message from MS paraffin blocks." Journal of the neurological sciences 385 (2018): 126-130.

Cagol et al. "Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis." JAMA neurology, 2022.

Benkert et al. "Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study." The Lancet Neurology 21.3 (2022): 246-257.

Oechtering et al. "Intrathecal immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis." Annals of neurology 90.3 (2021): 477-489.

Maggi et al. "Chronic white matter inflammation and serum neurofilament levels in multiple sclerosis." Neurology 97.6 (2021): e543-e553.


Publications in Google Scholar



Miriam Elmazi (Master student)

Merve Bastürk (Master student)



Copyright (c) Scancore 2018. All rights reserved.